Business
ARIUS to Present at Bio Week in Japan
ARIUS to Present at Bio Week in Japan.
About this update from Affinity Metals Corp
[{"type":"text","content":"\n\n\n\n\nTORONTO, Sept. 11 /CNW/ - ARIUS Research Inc. (\"ARIUS\") (TSX: ARI) today\nannounced that Dr. David Young, President and CSO of ARIUS has been invited to\nspeak about ARIUS and its business model during Bio Week 2006 in Japan.\n\"Our participation at Bio Japan in 2004 lead to our successful\ncollaboration with Takeda Pharmaceuticals, one of the largest Japanese\nPharmaceutical Companies,\" said Dr. David S. Young, President and Chief\nScientific Officer of ARIUS, \"We look forward to the 2006 opportunity to meet\nwith partners in this important market and increase the exposure of ARIUS. We\nare working to build value into our preclinical candidates and are seeking\nclinical collaborations to take the next step and begin the process of helping\ncancer patients.\"\nARIUS will be one of the presenting companies in an event organized by\nthe Canadian Embassy in Tokyo on September 11, 2006 at 2:00 pm. ARIUS will\nalso participate in BioJapan and the JETRO BioLink Forum 2006 in Osaka from\nSeptember 13-15 2006. ARIUS will describe recent developments from its\nanticancer antibody FunctionFIRST(TM) platform and available partnering\ncandidates. In addition, ARIUS will participate in a panel at the Canada-Japan\nScience and Technology 20th Anniversary Symposium: \"Bringing Science to Life\nthrough Commercialization\" in Tokyo on September 13, 2006.\n\nForward-Looking Statement\nCertain statements in this news release constitute \"forward-looking\nstatements\" within the meaning of the Private Securities Litigation Reform Act\nof 1995, which involve known and unknown risks, uncertainties and other\nfactors that may cause our actual results to be materially different from any\nfuture results, performance or achievements expressed or implied by such\nstatements. Forward-looking statements in this release include, but are not\nlimited to, ARIUS successfully advancing its new product programs as well as\nlicensing opportunities. These statements are only predictions and actual\nevents or results may differ materially. Factors that could cause such actual\nevents or results expressed or implied by such forward-looking statements to\ndiffer materially from any future results expressed or implied by such\nstatements include, but are not limited to: early stage of development;\ntechnology and product development; dependence on and man...